Journal Watch
Does dialysis time matter? YES!
Perhaps if in-center folks got more HD, they would see that they feel better—and think about home. Per Drs. Lacson and Lazarus from Fresenius, "Compelling rationale and recent outcome data support use of longer Td [dialysis time]...Until such time that results from prospective randomized trials are available, we believe that physicians should prescribe and exert all efforts to convince thrice-weekly hemodialysis patients to accept 4 h as minimum Td."
Read the abstract » | (added 2011-02-24)
Tags:
MYTHBUSTERS: microwaving PD fluid does NOT create glucose degradation products (GDPs)
While the belief persists that microwaving PD bags creates harmful GDPs when sugars are caramelized, the literature does not bear this out:
- A study in the ANNA Journal analyzed PD solution and found no changes, even when the fluid was superheated. The authors concluded that microwaving could be done safely.
- Very similar results were found in a study from PD International.
Read the abstract » | (added 2011-02-24)
Tags:
Female sexual function better on PD than standard in-center HD
If you're a woman, a new study finds that a transplant is the best way to restore your sexual function to normal levels. But PD did a much better job than standard HD—and the study didn't look at daily or nocturnal HD.
Read the abstract » | (added 2011-02-24)
Tags:
November 2006 Kidney International supplement focuses on PD
Is survival better on PD or HD? What factors predict PD success? What are best practices in PD catheter placement? Does use of biocompatible PD solution reduce peritonitis? Learn the answers to these and many other key PD questions in the November 2006 supplement of KI. (For kidney professionals who don't subscribe to Kidney International, we've compiled the links to all of the abstracts from the special supplement on PD (November 2006). You can find them below.
- Mortality studies comparing PD and HD: What do they tell us?
- French PD registry (RDPLF): Outline and main results
- PD in the US: Evaluation of outcomes in contemporary cohorts
- Selected best demonstrated practices in PD access
- Use of the embedded PD catheter: Experience and results from a North American Center
- Prevention of infectious complications in PD: Best demonstrated practices
- Microbiology and outcomes of peritonitis in North America
- Impact of new dialysis solutions on peritonitis rates
- Place of PD in the management of treatment-resistant congestive heart failure
- The role of PD in the management of treatment-resistant congestive heart failure: A European perspective
- Mitigating peritoneal membrane characteristics in modern PD therapy
- Profiles of automated PD prescriptions in the US 1997-2003
- Tidal PD: Its role in the current practice of PD
- The role of tidal PD in modern practice: A European perspective
- Glucose sparing in PD: Implications and metrics
- New insight of amino-acid based dialysis solutions
- Management of hyperlipidemia in patients on PD: Current approaches
- Structural requirements for a successful PD program
- Nosogogy: When the learner is a patient with chronic renal failure
- Patient retraining in PD: Why and when it is needed
- Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case-control study
- Place of genotyping and phenotyping in understanding and potentially modifying outcomes in PD patients
Read the abstract » | (added 2011-02-24)
Tags:
Need a bone density test on PD? Be sure you're empty
A new study has found that having fluid in your belly when you have a bone density test (called DXA) can change the results.
Read the abstract » | (added 2011-02-24)
Tags:
Take your vitamins
A new study finds that HD—with regular or high flux membranes—removes large amounts of water soluble vitamins.
Read the abstract » | (added 2011-02-24)
Tags:
Need high doses of EPO? Might want to check for CMV
A new study from the Netherlands has found that people who have ESRD and have been exposed to the cytomegalovirus (CMV) have immune changes. With fewer working T-cells, they can't respond as well to anemia drugs.
Read the abstract » | (added 2011-02-24)
Tags: Chronic kidney disease
On PD, higher uric acid levels predict faster loss of kidney function
Keeping as much of your kidney function as you can is a plus on PD or HD. A new study from Korea has found that people on PD whose levels of uric acid were higher had a faster decline in their kidney function. Those with higher blood pressure tended to have higher uric acid levels.
Read the abstract » | (added 2011-02-24)
Tags:
PKD is not a barrier to successful PD
In a study that compared 56 people with polycystic kidney disease on PD to 56 non-diabetic people with small kidneys on PD, there were no differences between the two groups after 37 months.
Read the abstract » | (added 2011-02-24)
Tags:
Need an MRI? Ask for NAC + bicarb
MRI contrast dye can damage kidneys. A new meta-analysis (study of studies) has found that two approaches are better than one in preventing this damage. N-acetylcystein (NAC, or Mucomyst®) plus bicarbonate-based IV fluid reduced the risk of damage by 35%. The authors say this combo treatment should be used for all high-risk patients—including those with CKD.
Read the abstract » | (added 2011-02-24)
Tags: Chronic kidney disease